Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Biodesix Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of BDSX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders3728−9
Shares3.72M4.75M+1.03M (+27.7%)
Value$5.99M$6.04M+$51.8K (+0.9%)

New holders (4)

Institutions that held Biodesix Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to BDSX in Q3 2022
InstitutionSharesValue% of portfolio
Essex Investment Management Co LLC378,023$480.0K0.08%
BNP Paribas Arbitrage, SA3,004$3.81K0.00%
Simplex Trading, LLC262$00.00%
Bogart Wealth, LLC180$00.00%

Sold out (13)

Institutions that held Biodesix Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of BDSX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Fred Alger Management, LLC130,908$215.0K
Chicago Capital, LLC23,365$38.0K
Ergoteles LLC22,223$36.0K
Two Sigma Securities, LLC13,169$22.0K
Goldman Sachs Group Inc10,850$18.0K
Blair William & Co10,800$18.0K
HRT Financial LP11,005$18.0K
Equitec Proprietary Markets, LLC6,900$11.0K
Federated Hermes, Inc.570$1.00K
Bank of America Corp200$0
FMR LLC269$0
New York State Common Retirement Fund108$0
Credit Suisse AG8$0